Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bijl

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Infection Control and Hospital Epidemiology|February 1, 1997
Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unitP E Verweij, D Bijl, W J Melchers, et al.
The European Respiratory Journal|July 22, 1999
Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patientsI D Bijl-Hofland, S G Cloosterman, H T Folgering, et al.
Chest|April 18, 2000
Perception of respiratory sensation assessed by means of histamine challenge and threshold loading testsI D Bijl-Hofland, S G Cloosterman, C P van Schayck, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthmaI D Bijl-Hofland, S G Cloosterman, H T Folgering, et al.
Respiratory Medicine|March 23, 2002
Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonistsC P van Schayck, S G M Cloosterman, I D Bijl-Hofland, et al.
The European Respiratory Journal|December 22, 1999
Perception of bronchoconstriction in asthma patients measured during histamine challenge testI D Bijl-Hofland, H T Folgering, H van den Hoogen, et al.
The European Respiratory Journal|March 2, 2002
Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthmaC P van Schayck, I D Bijl-Hofland, S G M Cloosterman, et al.
Chest|May 12, 2001
A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patientsS G Cloosterman, I D Bijl-Hofland, C L van Herwaarden, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 16, 1999
Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroidsS G Cloosterman, T R Schermer, I D Bijl-Hofland, et al.
Chemical Communications (Cambridge, England)|July 3, 2026
Wafer-scale robust graphene electronics under industrial processing conditionsE P van Geest, B S Can, M Makurat, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Infection Control and Hospital Epidemiology|February 1, 1997
Pseudo-outbreak of multiresistant Pseudomonas aeruginosa in a hematology unitP E Verweij, D Bijl, W J Melchers, et al.
The European Respiratory Journal|July 22, 1999
Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patientsI D Bijl-Hofland, S G Cloosterman, H T Folgering, et al.
Chest|April 18, 2000
Perception of respiratory sensation assessed by means of histamine challenge and threshold loading testsI D Bijl-Hofland, S G Cloosterman, C P van Schayck, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthmaI D Bijl-Hofland, S G Cloosterman, H T Folgering, et al.
Respiratory Medicine|March 23, 2002
Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonistsC P van Schayck, S G M Cloosterman, I D Bijl-Hofland, et al.
The European Respiratory Journal|December 22, 1999
Perception of bronchoconstriction in asthma patients measured during histamine challenge testI D Bijl-Hofland, H T Folgering, H van den Hoogen, et al.
The European Respiratory Journal|March 2, 2002
Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthmaC P van Schayck, I D Bijl-Hofland, S G M Cloosterman, et al.
Chest|May 12, 2001
A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patientsS G Cloosterman, I D Bijl-Hofland, C L van Herwaarden, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 16, 1999
Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroidsS G Cloosterman, T R Schermer, I D Bijl-Hofland, et al.
Chemical Communications (Cambridge, England)|July 3, 2026
Wafer-scale robust graphene electronics under industrial processing conditionsE P van Geest, B S Can, M Makurat, et al.
Pageof 3